hiPSCs from NS/JMML and NS patients with PTPN11 mutations model JMML
The hiPSC model reveals features of early oncogenesis
CD33<sup>+sup> myeloid cells from NS/JMML hiPSCs exhibit miR-223 dysregulation
MicroRNA dysregulation provides a genotype-phenotype association for JMML